EUVIMEDEUVIMED entdecken
Crossref

Dual‐Programmable Semiconducting Polymer NanoPROTACs for Deep‐Tissue Sonodynamic‐Ferroptosis Activatable Immunotherapy

Fengshuo Wang, Guoqiang Dong, Mengbin Ding, Ningyue Yu, Chunquan Sheng, Jingchao Li iD

Small · 2024

DOI: 10.1002/smll.202306378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2024. Verfasst von Fengshuo Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Biological Science and Medical Engineering, Donghua Univer…. Hauptthemen laut MEDLINE: Ferroptosis, Neoplasms. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteolysis‐targeting chimeras (PROTACs) can provide promising opportunities for cancer treatment, while precise regulation of their activities remains challenging to achieve effective and safe therapeutic outcomes. A semiconducting polymer nanoPROTAC (SPN FeP ) is reported that can achieve ultrasound (US) and tumor microenvironment dual‐programmable PROTAC activity for deep‐tissue sonodynamic‐ferroptosis activatable immunotherapy. SPN FeP is formed through a nano‐precipitation of a sonodynamic semiconducting polymer, a ferroptosis inducer, and a newly synthesized PROTAC molecule. The semiconducting polymers work as sonosensitizers to produce singlet oxygen ( 1 O 2 ) via sonodynamic effect under US irradiation, and ferroptosis inducers react with intratumoral hydrogen peroxide (H 2 O 2 ) to generate hydroxyl radical (·OH). Such a dual‐programmable reactive oxygen species (ROS) generation not only triggers ferroptosis and immunogenic cell death (ICD), but also induces on‐demand activatable delivery of PROTAC molecules into tumor sites. The effectively activated nanoPROTACs degrade nicotinamide phosphoribosyl transferase (NAMPT) to suppress tumor infiltration of myeloid‐derived suppressive cells (MDSCs), thus promoting antitumor immunity. In such a way, SPN FeP mediates sonodynamic‐ferroptosis activatable immunotherapy for entirely inhibiting tumor growths in both subcutaneous and 2‐cm tissue‐covered deep tumor mouse models. This study presents a dual‐programmable activatable strategy based on PROTACs for effective and precise cancer combinational therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisNeoplasmsAnimalsMiceImmunotherapyCombined Modality TherapyPolymersCell Line, TumorTumor Microenvironment

Stichwörter der Autor:innen

deep-tissue tumorsferroptosisimmunotherapyproteolysis-targeting chimeras (PROTACs)semiconducting polymers

Substanzen

Polymers

Autor:innen und Institutionen

  • State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Biological Science and Medical Engineering, Donghua University, Shanghai, 201620, China.
  • School of Pharmacy, Second Military Medical University, Shanghai, 200433, China.

ORCID-Profile: Jingchao Li

Förderung

  • National Natural Science Foundation of China
  • Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Wang, F., Dong, G., Ding, M., Yu, N., Sheng, C., & Li, J. (2024). Dual‐Programmable Semiconducting Polymer NanoPROTACs for Deep‐Tissue Sonodynamic‐Ferroptosis Activatable Immunotherapy. Small. https://doi.org/10.1002/smll.202306378

Vancouver

Wang F, Dong G, Ding M, Yu N, Sheng C, Li J. Dual‐Programmable Semiconducting Polymer NanoPROTACs for Deep‐Tissue Sonodynamic‐Ferroptosis Activatable Immunotherapy. Small. 2024. doi:10.1002/smll.202306378

BibTeX
@article{Wang2024,
  author = {Wang, Fengshuo and Dong, Guoqiang and Ding, Mengbin and Yu, Ningyue and Sheng, Chunquan and Li, Jingchao},
  title = {Dual‐Programmable Semiconducting Polymer NanoPROTACs for Deep‐Tissue Sonodynamic‐Ferroptosis Activatable Immunotherapy},
  journal = {Small},
  year = {2024},
  doi = {10.1002/smll.202306378}
}
Kostenlos starten →